Industry Partner for FRGS Application

Industry Partner for FRGS Application

Date : 17 February 2023

Reported by : Siti Nur Nazeha Bt Saiffuddin Zuhri

Category : Announcements



السَّلاَمُ عَلَيْكُمْ وَرَحْمَةُ اللهِ وَبَرَكَاتُهُ 

May this email reach you in the best of health and Iman by the grace of Allah Subhanahu Wata'ala.

Dear YBhg. Tan Sri/ Dato’/ Prof./ Dr./Sir./ Mdm.,

We would like to share with our respected researchers one of the companies that is available to collaborate with for your FRGS application.

About AGTC Genomics

AGTC (Advanced Genomic Technology Center) is a leading genomics center in the field of next-generation sequencing (NGS). With years of research and development experience, accurate and high-throughput sequencing services to meet every unique requirements of and eventually facilitating the advancement of precision medicine.

Equipped with the latest world-leading technology platforms and professional scientific staff, AGTC Genomics is dedicated in assisting our clients to accelerate their precision medicine research and cancer diagnostics. NGS is a critical tool as it provides individual patients the genomics information, which could be used to tailor therapy. AGTC Genomics integrates advanced technologies in NGS, microarray and big data analytics platforms to offer the most in-depth genomics data analyses. These tests are useful in finding genetic variants which assist in understanding, diagnosing and treating human diseases. Our goal is to help solve the mysteries of how diseases are induced by genetics and epigenetics, and eventually facilitating the advancement of precision medicine.


As an industry partner, they can provide the following resources:

Access to specialized equipment and facilities

Expertise in genomics, next-generation sequencing (NGS) and bioinformatics

Collaboration in project design and implementation

Assistance in commercializing the research results

If you are interested to collaborate with the company, do reach them at or WhatsApp at 0127988010.

Thank you.